STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

ZYXI director Form 3: insider reports zero beneficial ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Zynex, Inc. (ZYXI) reported a new director appointment disclosure. A Form 3 initial statement of beneficial ownership was filed indicating the reporting person is a Director and no securities are beneficially owned. The event date is 10/07/2025, and the filing was made by a single reporting person. This is a routine governance filing that establishes the insider’s baseline holdings at zero.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
WISE BRET W

(Last) (First) (Middle)
9655 MAROON CIRCLE

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/07/2025
3. Issuer Name and Ticker or Trading Symbol
ZYNEX INC [ ZYXI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Bret W Wise 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ZYXI disclose in this Form 3 filing?

A new insider baseline: the reporting person is a Director and reported no securities beneficially owned.

What is the event date in the ZYXI Form 3?

The date of the event requiring the statement is 10/07/2025.

Who filed the Form 3 for ZYXI?

It was filed by one reporting person; the signature block shows /s/ Bret W Wise.

What is the relationship of the reporting person to ZYXI?

The reporting person is listed as a Director.

Does the ZYXI insider own any shares or derivatives?

No. The filing states: “No securities are beneficially owned.”

What ticker and company are involved?

The issuer is Zynex, Inc. with ticker ZYXI.
Zynex Inc

NASDAQ:ZYXI

ZYXI Rankings

ZYXI Latest News

ZYXI Latest SEC Filings

ZYXI Stock Data

31.30M
15.75M
48.31%
18.33%
11.81%
Medical Distribution
Electromedical & Electrotherapeutic Apparatus
Link
United States
ENGLEWOOD